[HTML][HTML] Long-term dominance of carbapenem-non-susceptible pseudomonas aeruginosa ST111 in hematologic malignancy patients and hematopoietic cell …
L Zhang, FC Tan, L Strasfeld, M Hakki… - Frontiers in Cellular …, 2022 - frontiersin.org
An epidemiological study uncovered that fluoroquinolone (FQ) neutropenic prophylaxis in
hematopoietic cell transplant and hematologic malignancies (HCT/HM) patients was …
hematopoietic cell transplant and hematologic malignancies (HCT/HM) patients was …
Long-Term Dominance of Carbapenem-Non-Susceptible Pseudomonas aeruginosa ST111 in Hematologic Malignancy Patients and Hematopoietic Cell Transplant …
L Zhang, FC Tan, L Strasfeld… - Frontiers in cellular …, 2022 - pubmed.ncbi.nlm.nih.gov
An epidemiological study uncovered that fluoroquinolone (FQ) neutropenic prophylaxis in
hematopoietic cell transplant and hematologic malignancy (HCT/HM) patients was …
hematopoietic cell transplant and hematologic malignancy (HCT/HM) patients was …
Long-Term Dominance of Carbapenem-Non-Susceptible Pseudomonas aeruginosa ST111 in Hematologic Malignancy Patients and Hematopoietic Cell Transplant …
L Zhang, FC Tan, L Strasfeld, M Hakki… - Frontiers in Cellular …, 2022 - ohsu.elsevierpure.com
An epidemiological study uncovered that fluoroquinolone (FQ) neutropenic prophylaxis in
hematopoietic cell transplant and hematologic malignancy (HCT/HM) patients was …
hematopoietic cell transplant and hematologic malignancy (HCT/HM) patients was …
Long-Term Dominance of Carbapenem-Non-Susceptible Pseudomonas aeruginosa ST111 in Hematologic Malignancy Patients and Hematopoietic Cell Transplant …
L Zhang, FC Tan, L Strasfeld, M Hakki… - Frontiers in Cellular …, 2022 - europepmc.org
An epidemiological study uncovered that fluoroquinolone (FQ) neutropenic prophylaxis in
hematopoietic cell transplant and hematologic malignancy (HCT/HM) patients was …
hematopoietic cell transplant and hematologic malignancy (HCT/HM) patients was …
[HTML][HTML] Long-Term Dominance of Carbapenem-Non-Susceptible Pseudomonas aeruginosa ST111 in Hematologic Malignancy Patients and Hematopoietic Cell …
L Zhang, FC Tan, L Strasfeld, M Hakki… - Frontiers in Cellular …, 2022 - ncbi.nlm.nih.gov
An epidemiological study uncovered that fluoroquinolone (FQ) neutropenic prophylaxis in
hematopoietic cell transplant and hematologic malignancy (HCT/HM) patients was …
hematopoietic cell transplant and hematologic malignancy (HCT/HM) patients was …
Long-term dominance of carbapenem-non-susceptible Pseudomonas aeruginosa ST111 in hematologic malignancy patients and hematopoietic cell transplant …
L Zhang, FC Tan, L Strasfeld, M Hakki, NV Kirienko - 2022 - cabidigitallibrary.org
An epidemiological study uncovered that fluoroquinolone (FQ) neutropenic prophylaxis in
hematopoietic cell transplant and hematologic malignancy (HCT/HM) patients was …
hematopoietic cell transplant and hematologic malignancy (HCT/HM) patients was …
Long-Term Dominance of Carbapenem-Non-Susceptible Pseudomonas aeruginosa ST111 in Hematologic Malignancy Patients and Hematopoietic Cell Transplant …
L Zhang, FC Tan, L Strasfeld, M Hakki, NV Kirienko - 2022 - agris.fao.org
An epidemiological study uncovered that fluoroquinolone (FQ) neutropenic prophylaxis in
hematopoietic cell transplant and hematologic malignancy (HCT/HM) patients was …
hematopoietic cell transplant and hematologic malignancy (HCT/HM) patients was …
[PDF][PDF] Long-Term Dominance of Carbapenem-Non-Susceptible Pseudomonas aeruginosa ST111 in Hematologic Malignancy Patients and Hematopoietic Cell …
L Zhang, FC Tan, L Strasfeld, M Hakki… - Front. Cell. Infect …, 2022 - repository.rice.edu
An epidemiological study uncovered that fluoroquinolone (FQ) neutropenic prophylaxis in
hematopoietic cell transplant and hematologic malignancy (HCT/HM) patients was …
hematopoietic cell transplant and hematologic malignancy (HCT/HM) patients was …
Long-Term Dominance of Carbapenem-Non-Susceptible Pseudomonas aeruginosa ST111 in Hematologic Malignancy Patients and Hematopoietic Cell Transplant …
L Zhang, FC Tan, L Strasfeld, M Hakki… - Frontiers in Cellular …, 2022 - search.ebscohost.com
An epidemiological study uncovered that fluoroquinolone (FQ) neutropenic prophylaxis in
hematopoietic cell transplant and hematologic malignancy (HCT/HM) patients was …
hematopoietic cell transplant and hematologic malignancy (HCT/HM) patients was …
[PDF][PDF] Long-Term Dominance of Carbapenem-Non-Susceptible Pseudomonas aeruginosa ST111 in Hematologic Malignancy Patients and Hematopoietic Cell …
L Zhang, FC Tan, L Strasfeld, M Hakki… - Front. Cell. Infect …, 2022 - repository.rice.edu
An epidemiological study uncovered that fluoroquinolone (FQ) neutropenic prophylaxis in
hematopoietic cell transplant and hematologic malignancy (HCT/HM) patients was …
hematopoietic cell transplant and hematologic malignancy (HCT/HM) patients was …